EVH241115P20000
- 0.00
- 0.000.00%
Evolent Health Newsroom
Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39
Evolent Health Is Maintained at Buy by Citigroup
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $33
Press Release: Define Ventures Appoints Bruce Broussard as Venture Partner
Positive Sentiment Still Eludes Evolent Health, Inc. (NYSE:EVH) Following 25% Share Price Slump
Why Is Elevance Health Stock Trading Lower On Thursday?
TD Cowen Reaffirms Their Buy Rating on Evolent Health (EVH)
What's Next for Health Insurers as Medicare Finalizes 2025 Star Ratings?
Evolent Health Price Target Announced at $35.00/Share by Keybanc
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Evolent Health Initiated With an Overweight at KeyBanc
Evolent Health Inc (EVH) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says
Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts
Evolent Health Analyst Ratings
RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $42
Evolent Health (NYSE:EVH) Shareholders Are Still up 260% Over 5 Years Despite Pulling Back 4.0% in the Past Week
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63
TD Cowen Sticks to Their Buy Rating for Evolent Health (EVH)
J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $45